Decisions about add-on reimbursement for medical devices in France in the period July-September 2018

01

Nov 2018

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of many medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in the period July-September 2018.

Sixteen (16) decisions were released for prostheses:

  • NAOS (without cement), femoral stem (application for registration, because the data does not demonstrate interest for it)
  • ATHELIA II (with cement), dual mobility cotyle consisting of a cemented cup and a conventional polyethylene insert (application for registration, approved)
  • ATHELIA (without cement), dual mobility cotyle consisting of a cemented cup and a conventional polyethylene insert (application for registration, approved)
  • BI-MOBILE LINK (with cement), dual mobility cotyle consisting of a cemented cup and a conventional polyethylene insert (application for registration, rejected because the data does not demonstrate interest for it)
  • BI-MOBILE LINK (without cement), dual mobility cotyle consisting of a cemented cup and a conventional polyethylene insert (application for registration, rejected because the data does not demonstrate interest for it)
  • ATLANTIS Modular (without cement), femoral stem with modular collar (application for registration, approved)
  • BLUEPRO, advancement mandibular orthosis (application for registration, approved)
  • XO (without cement), modular collar (application for registration, approved)
  • XO (with cement), modular collar (application for registration, approved)
  • LOUXOR, modular collar (application for registration, approved)
  • H MAX M, hip prosthesis (element) – femoral stem (application for registration, approved)
  • SAM-FIT, hip prosthesis (element) – femoral stem (application for registration, rejected because the data does not demonstrate interest for it)
  • MINIMA M, hip prosthesis (element) – femoral stem (application for registration, rejected because the data does not demonstrate interest for it)
  • HARMONY (reference 4R146), controlled depressurization suspension system of the lower limb prosthesis (first cancelled; the amendment of the registration conditions and the renewal of registration approved later)
  • ECOFIT 2M and 2M SP, dual mobility acetabulum consisting of a no-cement cup and a conventional polyethylene insert (PEHR) (application for registration, rejected because the data does not demonstrate interest for it)
  • ECOFIT 2M (with cement), dual mobility acetabulum consisting of a no-cement cup and a conventional polyethylene insert (PEHR) (application for registration, rejected because the data does not demonstrate interest for it)

Eighteen (18) decisions were released for cardiovascular devices:

  • OPEN PIVOT, aortic duct with mechanical valve (application for registration, approved)
  • PRO KINETIC ENERGY, coronary stent coated with silicon carbide (product without pharmacological action) (renewal of registration, approved)
  • iSTENT Inject, trabecular microstrain stent (application for registration, approved)
  • CAVGJ 514 00, aortic duct with mechanical valve (renewal of registration, approved)
  • VAVGJ 515, (renewal of registration, approved)
  • RESOLUTE ONYX, coronary stent coated with zotarolimus (pharmacologically active product) (application for the amendment of the registration conditions, rejected)
  • IMPELLA 5.0, percutaneous electrical mechanical assistance device (left monoventricular, short duration) (application for registration - Title V, rejected)
  • IMPELLA CP, percutaneous electrical mechanical assistance device (left monoventricular, short duration) (application for registration - Title V, rejected)
  • ZENITH BRANCH, aortic stent (application for the amendment of the registration conditions and the renewal of registration, approved)
  • COREVALVE EVOLUT R, aortic valve bioprosthesis implanted by the transcutaneous arterial route (application for the amendment of the registration conditions, approved)
  • COREVALVE EVOLUT PRO, aortic valve bioprosthesis implanted by the transcutaneous arterial route (application for registration, approved)
  • COREVALVE AOA, aortic valve bioprosthesis implanted by the transcutaneous arterial route (application for the amendment of the registration conditions, approved)
  • COREVALVE EVOLUT AOA, aortic valve bioprosthesis implanted by the transcutaneous arterial route (application for the amendment of the registration conditions, approved)
  • CONFORMABLE TAG, thoracic aortic stent (application for the amendment of the registration conditions, approved)
  • MITRACLIP NTR, mitral ‘edge-to-edge’ repair clip (application for registration, approved)
  • MITRACLIP XTR, mitral ‘edge-to-edge’ repair clip (application for registration, approved)
  • SOLITAIRE 2, stent retriever (application for the amendment of the registration conditions, approved)
  • SOLITAIRE PLATINUM, stent retriever (application for the amendment of the registration conditions, approved)

Eighteen (18) decisions were released for other devices:

  • INVACARE COLIBRI OUTDOOR, modular electric scooter (application for registration, approved)
  • BAHA, osseointegrated hearing aid (cancelled in July, renewal of registration approved in August)
  • INFINITY, non-rechargeable system for deep brain stimulation (application for the amendment of the registration conditions, approved)
  • PRECISION MRI ASSEMBLY associated with the INFINION CX electrode, implantable and rechargeable medullary neurostimulation system (application for the amendment of the registration conditions, approved)
  • PRECISION NOVI associated with the INFINION CX electrode, implantable and non-rechargeable system of spinal neurostimulation (application for the amendment of the registration conditions, approved)
  • PRECISION SPECTRA associated with the INFINION CX electrode, implantable and rechargeable medullary neurostimulation system (application for the amendment of the registration conditions, approved)
  • COMET ALPINE +, modular electric scooter (application for registration, approved)
  • Ultrafill, system for home oxygen therapy with ambulation (application for the amendment of the registration conditions, approved)
  • GLACE, non-absorbable bone substitute (application for registration, approved)
  • BIOSEM II, centre-medullary cement shutter (renewal of registration, approved)
  • URGOSTART Interface, bandage (application for the amendment of the registration conditions and the renewal of registration, approved)
  • URGOSTART, bandage (application for the amendment of the registration conditions and the renewal of registration, approved)
  • URGOSTART Plus Compress, bandage (application for registration, approved)
  • URGOSTART Plus Border, bandage (application for registration, approved)
  • URGOSTART Border, bandage (application for the amendment of the registration conditions and the renewal of registration, approved)
  • ALBER E-MOTION M25, power assisted electric propulsion device for manual wheelchairs (application for registration, approved)
  • SOLEUS, class III energy recovery foot (application for registration, approved)
  • MINIMED 2007D, implantable pump system for intraperitoneal insulin delivery (renewal of registration, approved)

See list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more